Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Exosome Intranasal Instillation for the Treatment of Parkinson's Disease

Trial ID: NCT05152394

Interventional - Phase 1 - Recruiting

This trial will study the safety and efficacy of intranasal instillation of cultured allogeneic adult umbilical cord derived mesenchymal stem cell exosomes for the treatment of Parkinson's Disease

Conditions

• Parkinson Disease

Interventions

• AlloEx

Eligibility

Inclusion criteria

• Diagnosis of Parkinson's Disease
• Understanding and willingness to sign a written informed consent document

Exclusion criteria

• Active infection
• Active cancer
• Chronic multisystem organ failure
• Pregnancy
• Clinically significant Abnormalities on pre-treatment laboratory evaluation
• Medical condition that would (based on the opinion of the investigator) compromise patient's safety.
• Continued drug abuse
• Pre-menopausal women not using contraception
• Previous organ transplant
• Hypersensitivity to sulfur
• Anticoagulation medicine use

Sponsor

The Foundation for Orthopaedics and Regenerative Medicine

Source: ClinicalTrials.gov

Search more clinical trials on myTomorrows